The amyloid-β pathway in Alzheimer's disease

H Hampel, J Hardy, K Blennow, C Chen, G Perry… - Molecular …, 2021 - nature.com
Breakthroughs in molecular medicine have positioned the amyloid-β (Aβ) pathway at the
center of Alzheimer's disease (AD) pathophysiology. While the detailed molecular …

[HTML][HTML] Smoking and risk of negative outcomes among COVID-19 patients: a systematic review and meta-analysis

A Umnuaypornlert, S Kanchanasurakit… - Tobacco induced …, 2021 - ncbi.nlm.nih.gov
METHODS Electronic databases, including PubMed, EMBASE, Cochrane Library, Science
Direct, Google Scholar, were systematically searched from the initiation of the database until …

COVID-19 and the endocrine system: A review of the current information and misinformation

SA Mirza, AAE Sheikh, M Barbera, Z Ijaz… - Infectious Disease …, 2022 - mdpi.com
Coronavirus disease 2019 (COVID-19) infection primarily involves the respiratory system but
has many noteworthy extra pulmonary manifestations as well. We write this review to …

Impact of COVID-19 on poverty and living standards in Ghana: A micro-perspective

C Bukari, G Essilfie, MA Aning-Agyei… - Cogent Economics & …, 2021 - Taylor & Francis
The novel Coronavirus disease 2019 (COVID-19), which has become a global epidemic, hit
Ghana on 12 March 2020 and, in less than a week, increased by over 300% with two …

Gender specific differences in disease susceptibility: the role of epigenetics

L Migliore, V Nicoli, A Stoccoro - Biomedicines, 2021 - mdpi.com
Many complex traits or diseases, such as infectious and autoimmune diseases, cancer,
xenobiotics exposure, neurodevelopmental and neurodegenerative diseases, as well as the …

Host genetic diversity and genetic variations of SARS-CoV-2 in COVID-19 pathogenesis and the effectiveness of vaccination

M Delshad, MJ Sanaei… - International …, 2022 - Elsevier
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), responsible for the
outbreak of coronavirus disease 2019 (COVID-19), has shown a vast range of clinical …

COVID-19—The potential beneficial therapeutic effects of spironolactone during SARS-CoV-2 infection

K Kotfis, K Lechowicz, S Drożdżal… - Pharmaceuticals, 2021 - mdpi.com
In March 2020, coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 was
declared a global pandemic by the World Health Organization (WHO). The clinical course of …

Estrogen receptor modulators in viral infections such as SARS− CoV− 2: therapeutic consequences

N Abramenko, F Vellieux, P Tesařová, Z Kejík… - International Journal of …, 2021 - mdpi.com
COVID-19 is a pandemic respiratory disease caused by the SARS− CoV− 2 coronavirus.
The worldwide epidemiologic data showed higher mortality in males compared to females …

[HTML][HTML] COVID-19 vaccination for endocrine patients: a position statement from the Korean Endocrine Society

CR Ku, KY Jung, CH Ahn, JS Moon… - Endocrinology and …, 2021 - synapse.koreamed.org
Since the first outbreak of coronavirus disease 2019 (COVID-19), ongoing efforts have been
made to discover an efficacious vaccine against COVID-19 to combat the pandemic. In most …

Genetic association of ACE2 and TMPRSS2 polymorphisms with COVID-19 severity; a single centre study from Egypt

MH Elnagdy, A Magdy, W Eldars, M Elgamal… - Virology Journal, 2024 - Springer
Background Since the emergence of the COVID-19 infection in China, it has caused
considerable morbidity, mortality, and economic burden. It causes the vast majority of clinical …